GSK
GSK PLC ADR
Tracked managers · ownership rank #273 · master port 0.13% · dossier
No earnings events stored for GSK yet.
The name is tracked in the universe; consensus prints appear when the provider has them.
Private names (e.g. SpaceX) use company-announced dates when available.
SEC filings
Recent issuer filings from EDGAR · 25 shown
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | ADMISSION TO TRADING | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS | Filing Doc | |
| 6-K | BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE | Filing Doc | |
| 6-K | CAMLIPIXANT PHASE III RESULTS UPDATE | Filing Doc | |
| 6-K | AUDIT TENDER CONCLUSION | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | GSK COMPLETES ACQUISITION OF NUVALENT, INC | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ | Filing Doc | |
| 6-K | DIRECTORATE CHANGE | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | TOTAL VOTING RIGHTS | Filing Doc | |
| 6-K | HOLDING(S) IN COMPANY | Filing Doc | |
| 6-K | TRANSACTION IN OWN SHARES | Filing Doc | |
| 6-K | HOLDING(S) IN COMPANY | Filing Doc | |
| 6-K | GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | TRANSACTION IN OWN SHARES | Filing Doc | |
| 6-K | CUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDA | Filing Doc | |
| 6-K | TRANSACTION IN OWN SHARES | Filing Doc | |
| 6-K | MOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXAS | Filing Doc |
No filings match this filter.
Consensus estimates via FMP · SEC filings remain the official record · not investment advice